US Patent 7442793 Peptide deformylase inhibitors
Patent 7442793 was granted and assigned to Smithkline Beecham Limited on October, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+81 characters)
Article
Patent abstract
Novel PDF inhibitors and novel methods for their use are provided.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07442793 Peptide deformylase inhibitors US Patent 7442793 Peptide deformylase inhibitors
Infobox
Patent Number
0744279300
Patent Number
744279300
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074427930
Date of Patent
October 28, 2008
0Patent Application Number
105386250
Date Filed
December 11, 2003
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074427930
Date of Patent
October 28, 2008
0Patent Application Number
105386250
Date Filed
December 11, 2003
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07442793 Peptide deformylase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07442793
Date of patent
October 28, 2008
Patent application number
10538625
Date Filed
December 11, 2003
Patent primary examiner
Find more entities like US Patent 7442793 Peptide deformylase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
